Fundamental dimension Equity attribute | CNTMLeader $4.60▼-2.25% Cap $26.37MP/E -10.3x QuantScore37/100 | BLNKPeer $0.3816▼-3.44% Cap $55.31MP/E -1.0x QuantScore28/100 | CETYPeer $0.925▲+3.93% Cap $11.25MP/E -0.8x QuantScore23/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
60/100 |
23/100 |
44/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 0/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 12/100 | 28/100 | 16/100 |
Growth Revenue / earnings growth & margins | 76/100 | 33/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | 55/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -10.3x | -1.0x | -0.8x |
Forward P/E (next FY) | -1.1x | -1.7x | — |
EV / EBITDA (TTM) | -3.9x | -0.7x | -3.9x |
Price / Sales | 0.7x | 0.6x | 4.9x |
Price / Free Cash Flow | -2.3x | -1.1x | -1.4x |
PEG ratio | -0.02 | -0.00 | 0.07 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 3 / 9 | 0 / 9 |
Altman Z-Score | -1.74 (Distress) | -9.56 (Distress) | -3.67 (Distress) |
Total debt / equity | 1.19 | 0.09 | 0.65 |
Quick ratio | 0.2x | 1.0x | 0.9x |
Interest coverage | -5.4x | -2791.2x | -0.9x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +58.2% | -16.1% | -10.8% |
Net income growth YoY | +28.0% | +58.6% | -49.6% |
Gross margin (TTM) | 28.0% | 20.5% | -15.4% |
Operating margin (FY) | -33.6% | -72.4% | -118.4% |
FCF margin (FY) | -27.8% | -39.3% | -367.1% |
5. Trailing price performancePrice change over period |
1M return | -10.7% | -31.7% | -7.5% |
3M return | -21.2% | -27.1% | +0.6% |
6M return | -42.4% | -51.6% | +16.3% |
Year to date | -64.9% | -42.8% | +27.6% |
1Y return | -42.1% | -80.2% | -62.4% |
3Y return | -93.7% | -84.4% | -95.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-829.17 -18125.4% premium | $-41.89 -11077.7% premium | $-1.03 -211.9% premium |
Wall Street consensus target | — — | $10.30 +2599.2% · range $1.50–$25.00 | — — |
Consensus stance | — | 38% Buy62% Hold-0% Sell | — |